Liquidmetal (LQMT) 10-K 7 Mar 16 2015 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Mar. 03, 2016	Jun. 30, 2015
Entity Registrant Name	LIQUIDMETAL TECHNOLOGIES INC
Entity Central Index Key	1,141,240
Trading Symbol	lqmt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		477,149,485
Entity Public Float			$ 54,041,042
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash	$ 2,773,000	$ 10,009,000
Restricted cash	2,008,000	0
Trade accounts receivable, net of allowance for doubtful accounts	30,000	83,000
Inventory	83,000	0
Prepaid expenses and other current assets	408,000	374,000
Total current assets	5,302,000	10,466,000
Property and equipment, net	1,370,000	1,118,000
Patents and trademarks, net	570,000	669,000
Other assets	31,000	31,000
Total assets	7,273,000	12,284,000
Current liabilities:
Short-term debt	700,000	0
Accounts payable	250,000	155,000
Accrued liabilities	947,000	705,000
Deferred revenue	77,000	0
Total current liabilities	1,974,000	860,000
Long-term liabilities
Warrant liabilities	59,000	2,005,000
Other long-term liabilities	856,000	856,000
Total liabilities	$ 2,889,000	$ 3,721,000
Shareholders' equity (deficit):
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2015 and December 31, 2014, respectively
Common stock, $0.001 par value; 700,000,000 shares authorized; 477,149,485 and 464,482,819 shares issued and outstanding at December 31, 2015 and December 31, 2014, respectively	$ 477,000	$ 464,000
Warrants	18,179,000	18,179,000
Additional paid-in capital	203,735,000	200,610,000
Accumulated deficit	(217,945,000)	(210,636,000)
Non-controlling interest in subsidiary	(62,000)	(54,000)
Total shareholders' equity (deficit)	4,384,000	8,563,000
Total liabilities and shareholders' equity (deficit)	$ 7,273,000	$ 12,284,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	700,000,000	700,000,000
Common stock, shares issued (in shares)	477,149,485	464,482,819
Common stock, shares outstanding (in shares)	477,149,485	464,482,819

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenue
Products	$ 98,000	$ 565,000	$ 1,007,000
Licensing and royalties	27,000	38,000	19,000
Total revenue	125,000	603,000	1,026,000
Cost of sales	349,000	483,000	774,000
Gross profit (loss)	(224,000)	120,000	252,000
Operating expenses
Selling, marketing, general and administrative	7,010,000	7,463,000	5,157,000
Research and development	2,047,000	1,596,000	1,156,000
Total operating expenses	9,057,000	9,059,000	6,313,000
Operating loss	(9,281,000)	(8,939,000)	(6,061,000)
Change in value of warrants, gain (loss)	$ 1,946,000	$ 2,700,000	(2,155,000)
Change in value of embedded conversion feature liability, gain			621,000
Debt discount amortization expense	$ 0	$ (373,000)	$ (6,504,000)
Other income		30,000
Interest expense	$ (4,000)	0	$ (245,000)
Interest income	$ 22,000	$ 24,000	5,000
Gain on extinguishment of debt (Note 13)			91,000
Loss before income taxes	$ (7,317,000)	$ (6,558,000)	$ (14,248,000)
Income taxes
Net loss and comprehensive loss	$ (7,317,000)	$ (6,558,000)	$ (14,248,000)
Net loss attributable to non-controlling interest	8,000	12,000	42,000
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	$ (7,309,000)	$ (6,546,000)	$ (14,206,000)
Per common share basic and diluted:
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic (in dollars per share)	$ (0.02)	$ (0.01)	$ (0.04)
Net loss per common share attributable to Liquidmetal Technologies shareholders, diluted (in dollars per share)	$ (0.02)	$ (0.01)	$ (0.04)
Number of weighted average shares - basic (in shares)	470,955,041	441,439,018	341,451,559
Number of weighted average shares - diluted (in shares)	470,955,041	441,439,018	341,451,559

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Warrant [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2012		242,074,324
Balance at Dec. 31, 2012		$ 242,000	$ 18,179,000	$ 169,891,000	$ (189,884,000)		$ (1,572,000)
Conversion of preferred stock (in shares)	(506,936)	16,896,070
Conversion of preferred stock		$ 17,000		(17,000)
Stock Issued During Period, Shares, New Issues		116,136,796
Stock Issued During Period, Value, New Issues		$ 0		0	$ 0		$ 12,253,000
Stock option exercises (in shares)		600,000
Stock option exercises	$ 0	$ 0		0	0		75,000
Stock-based compensation	0	0		0	0		213,000
Restricted stock issued to officer	$ 0	$ 0		0	$ 0		312,000
Dividend distribution				$ 222,000			222,000
Net loss	$ 0	$ 0	$ 0		$ (14,206,000)	$ (42,000)	(14,248,000)
Balance (in shares) at Dec. 31, 2013		375,707,190
Balance at Dec. 31, 2013		$ 376,000	$ 18,179,000	$ 182,832,000	$ (204,090,000)	$ (42,000)	(2,745,000)
Stock option exercises (in shares)		600,000
Stock Issued During Period, Shares, New Issues		85,355,615
Stock Issued During Period, Value, New Issues		$ 85,000		15,915,000			$ 16,000,000
Stock option exercises (in shares)		2,242,014					2,242,014
Stock option exercises		$ 2,000		203,000			$ 205,000
Stock-based compensation				907,000			907,000
Restricted stock issued to officer				$ 312,000			$ 312,000
Dividend distribution
Net loss					$ (6,546,000)	$ (12,000)	$ (6,558,000)
Balance (in shares) at Dec. 31, 2014		464,482,819
Balance at Dec. 31, 2014		$ 464,000	$ 18,179,000	$ 200,610,000	$ (210,636,000)	$ (54,000)	8,563,000
Warrant exercises (in shares)		1,178,000
Warrant exercises		$ 1,000		225,000			$ 226,000
Stock option exercises (in shares)		2,242,014					2,242,014
Reclassification of warrant liability to equity upon exercise				216,000			$ 216,000
Stock Issued During Period, Shares, New Issues		12,500,000
Stock Issued During Period, Value, New Issues		$ 13,000		1,555,000			$ 1,568,000
Stock option exercises (in shares)		166,666					166,666
Stock option exercises				13,000			$ 13,000
Stock-based compensation				1,375,000			1,375,000
Restricted stock issued to officer				$ 182,000			$ 182,000
Dividend distribution
Net loss					$ (7,309,000)	$ (8,000)	$ (7,317,000)
Balance (in shares) at Dec. 31, 2015		477,149,485
Balance at Dec. 31, 2015		$ 477,000	$ 18,179,000	$ 203,735,000	$ (217,945,000)	$ (62,000)	$ 4,384,000
Stock option exercises (in shares)		166,666					166,666

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating activities:
Net loss	$ (7,317,000)	$ (6,558,000)	$ (14,248,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	522,000	301,000	$ 214,000
Gain on sale of fixed asset	$ 0	$ (5,000)
Bad debt expense			$ 11,000
Stock-based compensation	$ 1,375,000	$ 907,000	213,000
Restricted stock compensation issued to officer	182,000	312,000	312,000
(Gain) Loss from change in value of warrants	$ (1,946,000)	$ (2,700,000)	2,155,000
Gain from change in value of embedded conversion feature liability			(621,000)
Gain on extinguishment of debt (Note 13)			(91,000)
Debt discount amortization	$ 0	$ 373,000	6,504,000
Non-cash interest expense			242,000
Changes in operating assets and liabilities:
Trade accounts receivable	$ 53,000	$ 132,000	(162,000)
Inventory	(83,000)	0	0
Prepaid expenses and other current assets	$ (34,000)	38,000	$ (83,000)
Other assets		(3,000)
Accounts payable and accrued liabilities	$ 337,000	$ (216,000)	$ 577,000
Deferred revenue	77,000
Net cash used in operating activities	(6,834,000)	$ (7,419,000)	$ (4,977,000)
Investing Activities:
Purchases of property and equipment	(675,000)	(1,061,000)	(185,000)
Increase in restricted cash	(2,008,000)	0	0
Proceeds from sale of fixed assets	0	5,000	1,000
Investment in patents and trademarks	0	(9,000)	(13,000)
Net cash used in investing activities	(2,683,000)	(1,065,000)	(197,000)
Financing Activities:
Proceeds from short-term debt	700,000	0	0
Proceeds from exercise of stock options	13,000	205,000	$ 74,000
Proceeds from exercise of warrants	0	226,000
Proceeds from stock issuance	1,568,000	16,000,000
Net cash provided by financing activities	2,281,000	16,431,000	$ 74,000
Net increase (decrease) in cash	(7,236,000)	7,947,000	(5,100,000)
Cash at beginning of period	10,009,000	2,062,000	7,162,000
Cash at end of period	$ 2,773,000	$ 10,009,000	2,062,000
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Pre-installment payment of convertible debt through common stock issuance			7,187,000
Dividend distribution			222,000
Financing costs paid through common stock issuance			$ 373,000
Accrued capital expenditures		$ 5,000

Note 1 - Description of Busines

Note 1 - Description of Business	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	1 . Description of Business Liquidmetal Technologies, Inc. (the “Company”) is a materials technology and manufacturing company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops, manufactures and sells products and custom components from bulk amorphous alloys to customers in a wide range of industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. Amorphous alloys are , in general , unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. The Company’s alloys and the injection molding technology it employs results in components that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials. The Company’s revenues are derived from i) selling bulk Liquidmetal alloy products, which include non-consumer electronic devices, medical products, automotive components, and sports and leisure goods, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development , iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	2 . Summary of Significant Accounting Policies Principles of Consolidation. Non-Controlling Interest. Revenue Recognition The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal molds and bulk alloys, licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun. License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time. Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period. Cash. Trade Accounts Receivable. During 2015, there were three major customers, who together accounted for 52% of total revenue. During 2014, there were four major customers, who together accounted for 84% of total revenue. During 2013, there was one major customer, who accounted for 80% of total revenue. In the future, the Company expects that a significant portion of the revenue may continue to be concentrated in a limited number of customers, even if the bulk alloys business grows. The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the consolidated statements of operations and comprehensive loss. At December 31, 2015 and 2014, the Company had not recorded an allowance for doubtful accounts. Inventory. Property and Equipment. Intangible Assets. Impairment of Long-lived Assets Fair Value Measurements. The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, trade receivables , restricted cash, accounts payable, and short-term debt approximate their carrying value due to their short maturities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy: Level 1 — Quoted prices in active markets for identical assets or liabilities; Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has one financial instrument, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 measurement inputs. Warrants are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such warrants is estimated using the Black-Scholes option -pricing model. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815 (see note 14). As of December 31, 2015, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis: Fair Value Level 1 Level 2 Level 3 Warrant liabilities - - 59 - As of December 31, 2014, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis: Fair Value Level 1 Level 2 Level 3 Warrant liabilities - - 2,005 - Research and Development Expenses. Advertising and Promotion Expenses. Legal Costs. Stock-Based Compensation Share-based Payment Income Taxes. Accounting for Income Taxes Under the provisions of FASB ASC Topic 740, the Company had no material unrecognized tax positions and no adjustments to liabilities or operations were required. The Company, when applicable, will recognize interest and penalties related to uncertain tax positions in income tax expense. There was no expense related to interest and penalties for the years ended December 31, 2015, 2014 and 2013, respectively. Earnings Per Share. Use of Estimates. Subsequent Events. Supplemental Cash Flow Information. Recent Accounting Pronouncements. Revenue from Contracts with Customers In May 2014, the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective beginning January 1, 2018 and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements. Ability to Continue as a Going Concern In August 2014, the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements and accompanying disclosures. Inventory In July 2015, the FASB issued an accounting standards update which modifies the requirements for measuring the value of inventory on a periodic basis. The new requirement will be to measure inventory at the lower of cost or net realizable value. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements. Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 3 - Significant Transactio

Note 3 - Significant Transactions	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Significant Transactions [Text Block]	3 . Significant Transactions 201 4 Stock Purchase Agreement On August 20, 2014, the Company entered into a common stock purchase agreement (“2014 Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provides that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate of $30,000 worth of the Company’s common stock, $0.001 par value, over the 36 -month term of the 2014 Purchase Agreement. From time to time over the term of the 2014 Purchase Agreement, the Company may, at its sole discretion, provide Aspire Capital with a regular purchase notice (each a “Regular Purchase Notice”) directing Aspire Capital to purchase up to 1,000,000 shares, but not to exceed $400, of the Company’s common stock per trading day at a price per share equal to the lesser of (i) the lowest sale price of the Company’s common stock on the purchase date; or (ii) the arithmetic average of the three lowest closing sale prices for the Company’s common stock during the twelve consecutive trading days ending on the trading day immediately preceding the purchase date. In addition, on any date on which the Company submits a Regular Purchase Notice to Aspire Capital for the purchase of at least 500,000 shares at a price above $0.30, the Company also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of the Company’s common stock traded on its principal market on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice is The Company may deliver multiple Regular Purchase Notices and VWAP Purchase Notices to Aspire Capital from time to time during the term of the 2014 Purchase Agreement, so long as the most recent purchase has been completed. The 2014 Purchase Agreement provides that the Company and Aspire Capital shall not effect any sales under the 2014 Purchase Agreement on any purchase date where the closing sale price of the Company’s common stock is less than $0.10 per share. There are no trading volume requirements or restrictions under the 2014 Purchase Agreement, and the Company will control the timing and amount of sales of the Company’s common stock to Aspire Capital. On September 9, 2014, an initial registration statement covering 75,000,000 shares issued and issuable pursuant to the 2014 Purchase Agreement was declared effective by the SEC. As of December 31, 2015, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share. Line of Credit Facility In February 2015, the Company entered into a $2,000 line of credit facility, with a fixed interest rate of 2.1%, which originally matured on February 13, 2016. The facility has been extended through August 25, 2016, with reductions in available borrowings and associated collateral requirements to $1,000. Amounts available under this facility are secured by cash collateral. Such collateral is included as restricted cash on the Company’s consolidated balance sheet. As of December 31, 2015, there was $700 in outstanding borrowings under this facility. Interest expense applicable to these borrowings was $4 for the year ended December 31, 2015 and $0 for the years ended December 31, 2014 and 2013. 2013 Stock Purchase Agreement On November 8, 2013, the Company entered into a Common Stock Purchase Agreement (the “2013 Purchase Agreement”) with Kingsbrook Opportunities Master Fund LP, Tech Opportunities LLC, and Iroquois Master Fund Ltd. (each, a “2013 Investor” and collectively, the “2013 Investors”). The 2013 Purchase Agreement provided that each of the 2013 Investors had committed to purchase such 2013 Investor’s pro rata portion of up to $20,000 (the “Total Commitment”) worth of the Company’s common stock, $0.001 par value (the “Shares”), over the 36-month term of the 2013 Purchase Agreement. In consideration for the execution and delivery of the 2013 Purchase Agreement, on November 8, 2013, the Company issued 2,666,667 shares of common stock (“the Commitment Shares”) to the 2013 Investors. From time to time over the term of the 2013 Purchase Agreement, the Company was able to, at its sole discretion, provide each of the 2013 Investors with draw down notices (each a “Draw Down Notice”) requiring them to purchase a specified dollar amount of Shares (the “Draw Down Amount”) over a five (5) consecutive trading day period commencing on the trading day specified in the applicable Draw Down Notice (the “Pricing Period”) with each draw down subject to certain limitations. The maximum amount of Shares requested to be purchased pursuant to any single Draw Down Notice could not exceed a dollar amount equal to the lesser of (i) 300% of the average trading volume of the Company’s common stock during the ten (10) trading days immediately preceding the date the applicable Draw Down Notice was delivered (the “Applicable Draw Down Exercise Date”) multiplied by the lower of (A) the closing trade price of the Company’s common stock on the trading day immediately preceding the Applicable Draw Down Exercise Date and (B) the average of the closing trade prices of our common stock for the three (3) trading days immediately preceding the Applicable Draw Down Exercise Date (such lower price, the “Reference Price”), and (ii) a specified dollar amount set forth in the 2013 Purchase Agreement based on the Reference Price as of the Applicable Draw Down Exercise Date. As of December 31, 2014, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014. July 2012 Private Placement On July 2, 2012, the Company entered into a private placement transaction (the “July 2012 Private Placement”) pursuant to which the Company issued $12,000 in principal amount of senior convertible notes that were due on September 1, 2013. The notes were convertible into shares of the Company’s common stock at a conversion price of $0.352 per share. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012. Each monthly installment payment was payable in cash, shares of the Company’s common stock, or a combination thereof. If paid in shares, such shares were valued at the lower of (i) the then applicable conversion price or (ii) a price that was 87.5% of the arithmetic average of the ten (or in some cases fewer) lowest weighted average prices of the Company’s common stock during the twenty trading day period ending two trading days before the payment date or the date on which the Company elected to pay in shares, whichever was lower. As of July 17, 2013, the Company had issued 163,641,547 shares of common stock in full satisfaction of the notes (see note 13). As a part of the July 2012 Private Placement, the Company issued warrants to purchase 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share (reduced to $0.19 per share under the anti-dilution and price reset provisions of the warrants, see note 14), and such warrants first became exercisable on January 2, 2013 which was six months after the issuance date thereof. In the event that the Company issues or sells shares of the Company’s common stock at a price per share that is less than the exercise price then in effect, the exercise price of the warrants will be reduced based on a weighted-average formula. In addition, on the two-year anniversary of the issuance date, the then applicable exercise price was reset to equal 87.5% of the arithmetic average of the ten lowest weighted average prices of the common stock during the twenty trading day period ending two trading days immediately preceding the reset date. All of the warrants will expire on July 2, 2017 (see note 14). Apple License Transaction On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Additionally, in connection with the license transaction, Apple required the Company to complete a statement of work related to the exchange of Liquidmetal intellectual property information. The Company recognized a portion of the one-time license fee upon receipt of the initial payment and completion of the foregoing requirements under the license transaction. The remaining portion of the one-time license fee was recognized at the completion of the required statement of work. Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property that it developed through February 2012. Subsequently, this obligation has been extended to apply to all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction. Visser Precision Cast, LLC License Agreement On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. Under the manufacturing and service component of the Visser MTA, the Company had agreed to engage Visser as a perpetual, exclusive manufacturer of non-consumer electronic products. Under the financing component of the Visser MTA, the Company issued and sold to Visser in a private placement transaction (i) 30,000,000 shares of common stock at a purchase price of $0.10 per share resulting in proceeds of $3,000 and (ii) two warrants to purchase 15,000,000 shares of common stock at an original exercise price of $0.22 per share which expire on June 1, 2017. On May 20, 2014, the Company and Visser entered into a settlement agreement whereby the parties have amended and restated the sublicense and financing components of the Visser MTA. Additionally, the manufacturing services component and remaining considerations of the Visser MTA were terminated. Under the amended and restated sublicense agreement, the Company has granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 (the “Effective Date”), for all fields of use other than certain excluded fields as set forth therein. Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement. With the foregoing revised arrangements, the Company is no longer required to use Visser as its exclusive manufacturer and is free to license other manufacturers on a non-exclusive basis in any industry or geographic market as to which the Company has not previously granted an exclusive license to a third party. Any such manufacturers licensed by the Company in the future will be able both to manufacture parts for the Company and the Company’s customers , and to manufacture and sell products for their own account for such industries or markets as the Company may agree, subject to whatever royalty arrangements the Company may negotiate. The Company has not yet licensed any manufacturers other than Visser. Visser will also have the right to manufacture and sell products under the amended and restated sublicense agreement. The settlement amended and restated the two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. Those warrants contained anti-dilution mechanisms under which the number of shares issuable upon exercise of those warrants would be increased, and the exercise price for such shares would be reduced if the Company issued shares of its common stock at prices less than the warrants’ exercise price. The amended and restated warrant agreement includes the effect of such anti-dilution adjustments and is exercisable for 18,611,079 shares of common stock (increased further to 18 ,937,931 shares under the anti-dilution provisions of the warrants, see note 14) at an exercise price of $0.17 per share. The amended and restated warrant agreement continues to contain comparable anti-dilution adjustment mechanisms. The amended and restated warrant agreement also removes certain lock-up provisions that were included in the original warrants. Other License Transactions On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel. On December 6, 2013, the companies entered into an Exclusive License Agreement for a 10 year term whereby Engel was granted an exclusive license to manufacture and sell injection molding machines to the Company’s licensees in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines. The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf. In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”). Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including the Company), but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Note 4 - Liquidity and Capital

Note 4 - Liquidity and Capital Resources	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Liquidity and Capital Resources [Text Block]	4 . Liquidity and Going Concern Issues As of December 31, 2015, the Company’s cash and restricted cash balance was $4,781, which consisted of $2,773 of cash and $2,008 of short-term restricted cash . The Company will need to raise funds during 2016 to be able to continue its operations beyond 2016. The consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary if the Company were unable to continue as a going concern. The Company has a relatively limited history of producing bulk amorphous alloy components and products on a mass-production scale. Furthermore, the ability of future contract manufacturers to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. These factors will likely require that the Company make further equity sales under the 2014 Purchase Agreement, raise additional funds by other means, or pursue other strategic initiatives to support its operations beyond 2016. There is no assurance that the Company will be able to make equity sales under the 2014 Purchase Agreement or raise additional funds by other means on acceptable terms, if at all. If the Company were to make equity sales under the 2014 Purchase Agreement or to raise additional funds through other means by issuing securities, existing stockholders may be diluted. If funding is insufficient at any time in the future, the Company may be required to alter or reduce the scope of its operations or to cease operations entirely. Uncertainty as to the outcome of these factors raises substantial doubt about the Company’s ability to continue as a going concern. For the year ended December 31, 2015, the Company’s cash used in operations was $6,834, cash used in investing activities was $2,683, primarily due to increases in restricted cash to support the line of credit facility, and cash provided by financing activities was $2,281, primarily due to cash received from equity sales under the 2014 Purchase Agreement and borrowings under the line of credit. On August 20, 2014, the Company entered into the 2014 Purchase Agreement which allows it to raise up to $30,000 through periodic issuances of common stock over a three year period. The Company may not raise funds through the 2014 Purchase Agreement when the closing sales price of the Company’s common stock is less than $0.10 per share. As of December 31, 2015, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share.

Note 5 - Trade Accounts Receiva

Note 5 - Trade Accounts Receivable	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	5 . Trade accounts receivable Trade accounts receivable were comprised of the following: December 31, 2015 2014 Trade accounts receivable $ 30 $ 83 Less: Allowance for doubtful accounts - - Trade accounts receivable, net $ 30 $ 83

Note 6 - Prepaid Expenses and O

Note 6 - Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Prepaid Expenses and Other Current Assets [Text Block]	6 . Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets totaled $408 and $374 as of December 31, 2015 and December 31, 2014, respectively. Included within these totals as of December 31, 2015 and 2014 are the following: December 31, 2015 2014 Prepaid service invoices $ 48 $ 43 Prepaid manufacturing and mold costs 118 73 Prepaid insurance premiums 192 193 Other receivables 50 65 Total 408 374

Note 7 - Inventory

Note 7 - Inventory	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Inventory Disclosure [Text Block]	7. Inventory Inventory totaled $83 and $0 as of December 31, 2015 and December 31, 2014, respectively, and primarily consisted of raw alloy and finished goods inventory to satisfy future customer orders. Inventory is stated at the lower of weighted-average cost or market.

Note 8 - Property and Equipment

Note 8 - Property and Equipment	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	8 . Property and Equipment Property and equipment consist of the following: December 31, 2015 2014 Machinery and equipment $ 2,545 $ 1,903 Computer equipment 218 218 Office equipment, furnishings, and improvements 564 531 Total 3,327 2,652 Accumulated depreciation (1,957 ) (1,534 ) Total property and equipment, net $ 1,370 $ 1,118 Depreciation expense for the years ended December 31, 2015, 2014 and 2013 was $423, $197, and $96, respectively. For the year ended December 31, 2015, $29 of depreciation expense was included in cost of sales and $394 was included in selling, marketing, general and administrative expenses. For the years ended December 31, 2014 and 2013, $0 of depreciation expense was included in cost of sales and $197 and $96, respectively, was included in selling, marketing, general and administrative expenses.

Note 9 - Patents and Trademarks

Note 9 - Patents and Trademarks, Net	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	9 . Patents and trademarks, net Patents and trademarks consist of the following: December 31, 2015 2014 Purchased and licensed patent rights $ 566 $ 566 Internally developed patents 1,664 1,664 Trademarks 148 148 Total 2,378 2,378 Accumulated amortization $ (1,808 ) $ (1,709 ) Total intangible assets, net $ 570 $ 669 Amortization expense was $99, $104, and $118 for the years ended December 31, 2015, 2014, and 2013, respectively, and is included in research and development expense in the consolidated statements of operations and comprehensive loss. The estimated aggregate amortization expense for each of the five succeeding years is as follows: December 31, Aggregate Amortization Expense 2016 $ 97 2017 86 2018 84 2019 83 2020 80 Thereafter 140 $ 570 Accumulated amortization for the years ended December 31, 2015 and 2014 is as follows: December 31, 2015 2014 Purchased and licensed patent rights $ (517 ) $ (500 ) Internally developed patents (1,177 ) (1,103 ) Trademarks (114 ) (106 ) Total $ (1,808 ) $ (1,709 ) The weighted average amortization periods for the years ended December 31, 2015 and 2014 are as follows: December 31, 2015 2014 Purchased and licensed patent rights 17 17 Internally developed patents 17 17 Trademarks 10 10 Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreements. In addition to the purchased and licensed patents, the Company has capitalized legal and registration costs incurred to obtain and maintain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

Note 10 - Short-Term Debt

Note 10 - Short-Term Debt	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Short-term Debt [Text Block]	10. Short-Term Debt Short-term debt totaled $700 and $0 as of December 31, 2015 and December 31, 2014, respectively, and consisted of borrowings under a line of credit facility, with a fixed interest rate of 2.1%. Interest expense related to outstanding borrowings was $4, $0, and $0 for the years ended December 31, 2015, 2014, and 2013, respectively. This credit facility requires the Company to maintain collateral for the full amount of the facility. A failure to meet this requirement could trigger a prepayment of all outstanding borrowings. Given the proximity to maturity, the carrying amount of short-term debt approximates fair value.

Note 11 - Accrued Liabilities

Note 11 - Accrued Liabilities	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	11 . Accrued Liabilities Accrued liabilities totaled $947 and $705 as of December 31, 2015 and December 31, 2014, respectively. Included within these totals are employee related accruals for normal wages, bonuses, and vacation liabilities, of $766 and $567, as well as accrued audit fees of $109 and $95 as of December 31, 2015 and 2014, respectively. In addition, as of December 31, 2015 and 2014, respectively, $72 and $43 of deferred straight-line rent liabilities existed related to the Company’s warehouse and office facility lease.

Note 12 - Other Long-term Liabi

Note 12 - Other Long-term Liabilities	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Other Liabilities Disclosure [Text Block]	12 . Other Long-Term Liabilities Other Long-term Liabilities balance of $856 and $856 as of December 31, 2015 and 2014, respectively, consists of long term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or write-off in accordance with applicable accounting rules.

Note 13 - Convertible Notes, Em

Note 13 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Debt Disclosure [Text Block]	1 3 . Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt On July 2, 2012, the Company entered into the July 2012 Private Placement for $12,000 in principal amount of senior convertible notes due on September 1, 2013 (see note 3) . The notes were convertible at any time at the option of the holders, into shares of the Company’s common stock at a conversion price of $0.352 per share. Pursuant to ASC 815-40, due to the anti-dilution provision of the convertible notes, the conversion feature of the convertible notes was not indexed to the Company’s own stock and was bifurcated and recognized as a derivative liability in the consolidated balance sheets and measured at fair value. The notes bore interest at 8% per annum and were payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012 . The embedded conversion feature liability and warrants issued in connection with the senior convertible notes were valued utilizing the Monte Carlo simulation and Black -Scholes pricing model at $8,865 and $5,053, respectively, totaling $13,918 as of July 2, 2012. $12 ,000 of this total was recorded as debt discount and the excess of the face value of the embedded conversion feature liability and warrants of $1,918 was booked to debt discount amortization on July 2, 2012. Pursuant to the terms of the Senior Convertible Notes, the Company opted to pay the first eleven monthly installment payments due prior to June 30, 2013 with shares of the Company’s common stock. On July 17, 2013, the Company and each of the holders of the Senior Convertible Notes agreed to cause all remaining principal and interest under the Senior Convertible Notes to be converted into an aggregate of 18,679,584 shares of the Company’s common stock in full satisfaction of the notes. As a result of this conversion, the Senior Convertible Notes were paid off in full and are no longer outstanding as of the conversion date. As the final conversion occurred pursuant to terms that were not included in the original terms of the Senior Convertible Notes, the Company recorded a gain on extinguishment of debt in the amount of $91 which consisted of the write-off of unamortized debt discount, unamortized debt issuance costs, embedded conversion feature liabilities, and the difference between the reacquisition price of the shares issued and the contractual conversion price of the Senior Convertible Notes. Upon final settlement, the Company had issued 163,641,547 shares of common stock , at a weighted average conversion price of $0.0774, for the twelve installment payments due under the Senior Convertible Notes, consisting of $12,000 principal and $680 of interest.

Note 14 - Warrant Liabilities

Note 14 - Warrant Liabilities	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Derivatives and Fair Value [Text Block]	1 4 . Warrant Liabilities Pursuant to FASB ASC 815, the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of warrants. During June 2012, the Company issued warrants to purchase a total of 15,000,000 shares of common stock to Visser under the Visser MTA (see note 3). These warrants had an original exercise price of $0.22 per share and expire on June 1, 2017 and were originally valued at $4,260. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of subsequent issuances of the Company’s common stock, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to $0.17 and $0.18 as of December 31, 2015 and December 31, 2014, respectively. In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to 18,937,931 and 18,706,235 as of December 31, 2015 and December 31, 2014, respectively. As of December 31, 2015, these warrants were valued at $34 using the Black -Scholes valuation model utilizing the following assumptions: (i) expected life of 1.42 years, (ii) volatility of 57%, (iii) risk-free interest rate of 1.1%, and (iv) dividend rate of 0. The change in warrant value for these warrants for the years ended December 31, 2015, 2014 and 2013 was a gain (loss) of $1,019, $1,506, and $(1,299), respectively. On July 2, 2012, the Company issued warrants to purchase a total of 18,750,000 shares of common stock related to the July 2012 Private Placement (see note 3). These warrants had an exercise price of $0.384 per share and expire on July 2, 2017 and were originally valued at $5,053. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of executed draw-downs under the 2013 and 2014 Purchase Agreements, which resulted in an anti-dilution impact, as well as contractually defined price resets following the second anniversary of the July 2012 Private Placement, the exercise price of these warrants was reduced to $0.19 as of December 31, 2015 and December 31, 2014 . As of December 31, 2015 there were warrants to purchase a total of 17,572,000 shares of common stock outstanding, which were valued at $25 using the Black -Scholes valuation model utilizing the following assumptions: (i) expected life of 1 .50 years, (ii) volatility of 56%, (iii) risk-free interest rate of 1.1%, and (iv) dividend rate of 0. The change in warrant value for these warrants for the years ended December 31, 2015, 2014 and 2013 was a gain (loss) of $927, $1,194, and $(856), respectively. The following table summarizes the change in the Company’s warrant liability for the year ended December 31, 2015: Visser MTA July 2, 2012 Total Beginning Balance - December 31, 2014 $ 1,053 $ 952 2,005 Change in value of warrant liability, gain $ (1,019 ) $ (927 ) (1,946 ) Ending Balance - December 31, 2015 $ 34 $ 25 $ 59 As of December 31, 2015 and 2014, the Company had 36,509,931 and 66,057,792 warrants outstanding, respectively . As of December 31, 2015 and 2014, the Company valued the 36,509,931 and 36,278,235 warrants classified as liabilities using the Black-Scholes model and recorded $59 and $2,005 respectively, in warrant liabilities. The change in fair value of warrants resulted in a total non-cash gain of $1,946 and $2,700 for the years ended December 31, 2015 and 2014, respectively. The fair value of warrants outstanding for the following periods was computed using the Black-Scholes model under the following assumptions: December 31, 2015 2014 Expected life in years 1.42 - 1.50 2.42 - 2.50 Volatility 56% - 57% 96% - 97% Risk-free interest rate 1.1% 1.1% Dividend rate 0% 0% As of December 31, 2015, outstanding warrants to acquire shares of the Company’s common stock are as follows: Number of Shares Exercise Price Expiration Date 18,937,931 $ 0.174 June 1, 2017 17,572,000 $ 0.190 July 2, 2017 36,509,931

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	1 5 . Shareholders’ Equity ( Defici t) Common stock In June 2012, the Company issued 30,000,000 shares of common stock to Visse r in connection with the Visse r MTA (see note 3). Pursuant to the terms of the Company’s Senior Convertible Notes issued in the July 2012 Private Placement, the Company opted to pay the twelve monthly installment payments prior to the September 1, 2013 maturity date with shares of the Company’s common stock. Upon final settlement, the Company had issued 163,641,547 shares of common stock at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 principal and $680 of interest (see notes 3 and 13). During the year ended December 31, 2013, the holders of the Company’s Series A Preferred Stock converted all of the outstanding 506,936 shares of preferred stock into 16,896,070 shares of the Company’s common stock (see “Preferred stock” below). After giving effect to such conversion, the Company has no shares of preferred stock outstanding. On February 28, 2013, the Company’s stockholders approved an amendment to the Certificate of Incorporation of the Company increasing the number of authorized shares of common stock from 400 million shares to 500 million shares. On October 24, 2013, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 500 million shares to 700 million shares . In connection with the execution of the 2013 Purchase Agreement, the Company issued to each of the 2013 Investors a pro rata portion of 2,666,667 shares of the Company’s common stock. As of December 31, 2014, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014 (see Note 3). On September 9, 2014, an initial registration statement covering 75,000,000 shares issued and issuable pursuant to the 2014 Purchase Agreement was declared effective by the SEC. As of December 31, 2015, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share (see Note 3). Preferred stock On May 1, 2009, pursuant to a Securities Purchase and Exchange Agreement, the Company issued 500,000 shares of convertible Series A-1 Preferred Stock with an original issue price of $5.00 per share and 2,625,000 shares of Series A-2 Preferred Stock with an original issue price of $5.00 per share as part of a financing transaction. In October 2009, the Company entered into an agreement with various investors to issue 180,000 shares of Series A-1 Preferred Stock with identical terms as the Series A-1 Preferred Stock issued on May 1, 2009. The Series A Preferred Stock and any accrued and unpaid dividends thereon was convertible, at the option of the holders of the Series A Preferred Stock, into common stock of the Company at a conversion price of $ 0.10 per share in the case of the Series A-1 Preferred Stock and a conversion price of $ 0.22 per share in the case of the Series A-2 Preferred Stock (in both cases subject to adjustments for any stock dividends, splits, combinations and similar events). During the year ended December 31, 2012, the holders of the Company’s Series A Preferred Stock converted 792,215 shares of preferred stock into 25,669,752 shares of the Company’s common stock. As of December 31, 2012, the Company had 506,936 shares of Series A Preferred Stock outstanding, consisting of 105,231 and 401,705 shares of Series A-1 and Series A-2 Preferred Stock , respectively. Preferred stock as of December 31, 2012 was $0 due to an insignificant balance, and accrued dividends on the Series A Preferred Stock as of December 31, 2012 were $222. During the year ended December 31, 2013 , all of the holders of the Company’s Series A Preferred Stock converted all of the outstanding shares of preferred stock and accrued dividends into 16,896,070 shares of the Company’s common stock. Therefore, as of December 31, 2013, the Company no longer had any outstanding Preferred Stock and the related $222 accrued dividends were reclassified to additional paid-in capital as of December 31, 2013. Warrants In connection with the Series A Preferred Stock issuances in 2009, warrants to purchase 29,779,557 shares of the Company’s common stock, valued at $18,179, were outstanding through July 15, 2015. Due to extension of the expiration date of these warrants during 2010, they no longer contained anti-dilution provisions and were reflected as equity as they did not meet the criteria under FASB ASC 815 for liability treatment. Such warrants had exercise prices ranging between $0.48 and $0.49 and expired on July 15, 2015.

Note 16 - Stock Compensation Pl

Note 16 - Stock Compensation Plan	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	1 6 . Stock Compensation Plan On April 4, 2002, our shareholders and Board of Directors adopted the 2002 Equity Incentive Plan (“2002 Plan”). The 2002 Plan provides for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of 10,000,000 shares of our common stock may be granted under the 2002 Plan. The 2002 Plan expired by its terms in April 2012, but it will remain in effect only with respect to the equity awards that have been granted prior to its expiration. As of December 31, 2015, there were 822,000 options outstanding under the 2002 Plan. On June 28, 2012, the Company adopted the 2012 Equity Incentive Plan (“2012 Plan”) , with the approval of the shareholders , which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. The 2012 Plan provides for the granting to employees of incentive stock options within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, and for the granting to employees and consultants of non -statutory stock options. In addition, the Plan permits the granting of stock appreciation rights, or SARs, with or independently of options, as well as stock bonuses and rights to purchase restricted stock. A total of 30,000,000 shares of the Company’s common stock may be granted under the 2012 Equity Incentive Plan, and all options granted under this plan had exercise prices that were equal to the fair market value on the date of grant. During 2015, the Company granted options to purchase 3,085,001 shares of common stock , with total options outstanding of 25,988,734 as of December 31, 2015. On January 27, 2015, the Company adopted its 2015 Equity Incentive Plan (“2015 Plan”) , which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries . A total of 40,000,000 shares of the Company’s common stock are available for issuance under the 2015 Plan . All options granted under the 2015 Plan had exercise prices that were equal to the fair market value on the dates of grant. During 2015, the Company granted options to purchase 17,200,000 shares of common stock , with total options outstanding of 15,100,000 as of December 31, 2015. FASB ASC 718, Compensation – Stock Compensation, On August 3, 2010, in conjunction with an employment agreement with Thomas Steipp, the Company’s Chief Executive Officer, the Company also granted an aggregate of 6,000,000 restricted shares of the Company’s common stock, which will ratably vest each year over five years. During the years December 31, 2015, 2014, and 2013, the Company recorded $182, $312, and $312, respectively, of compensation expense related to Mr. Steipp’s restricted shares, which are included in the stock-based compensation totals above. The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the assumptions noted in the following table. December 31, 2015 2014 2013 Expected volatility 84.19% - 168.46% 157.24% - 179.87% 128.55% - 168.09% Expected dividends - - - Expected term (in years) 0.73 - 6.32 5.50 - 7.50 6.32 - 9.61 Risk-free rate 0.39% - 1.96% 1.65% - 2.22% 1.26% - 2.49% Expected volatilities are based on historical volatility expected over the expected life of the options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. Forfeiture rates of 5.34%, 7.01% and 28.3% were used for options granted during the years ended December 31, 2015, 2014 and 2013, respectively. The risk free rate for period within the expected life of the options is based on U.S. Treasury rates in effect at the time of grant. The following table summarizes the Company’s stock option transactions for the years ended December 31, 2015 and 2014: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Options outstanding at December 31, 2013 15,734,500 0.13 Granted 15,292,914 0.29 Exercised (2,242,014 ) 0.09 Forfeited (1,219,501 ) 0.20 Expired (25,000 ) 1.43 Options outstanding at December 31, 2014 27,540,899 0.21 Granted 20,285,001 0.14 Exercised (166,666 ) 0.08 Forfeited (4,933,500 ) 0.18 Expired (815,000 ) 0.64 Options outstanding at December 31, 2015 41,910,734 $ 0.18 7.8 $ - Options exercisable at December 31, 2015 10,424,408 $ 0.18 7.3 $ - Options unvested at December 31, 2015 31,486,326 $ 0.17 7.9 $ - Options vested or expected to vest at December 31, 2015 38,032,146 $ 0.18 7.8 $ - The following table provides supplemental data on stock options for the years ended December 31, 2015, 2014 and 2013: December 31, 2015 2014 2013 Weighted average grant date fair value per option granted $ 0.12 $ 0.28 $ 0.08 Fair value of options vested 1,584 385 54 Cash from participants to exercise stock options 13 205 74 Intrinsic value of options exercised 8 385 22 The following table summarizes the Company’s stock options outstanding and exercisable by ranges of option prices as of December 31, 2015: Options Outstanding Options Exercisable Range of Exercise Prices Numbers of Options Outstanding Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Number of Options Exercisable Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price $0.00 - 0.10 10,340,820 6.99 $ 0.08 4,701,724 7.01 $ 0.08 0.11 - 1.442 31,569,914 8.01 0.21 5,722,684 7.48 0.26 Total 41,910,734 10,424,408 The Company’s non-vested options at the beginning and ending of fiscal year 2015 had weighted-average grant-date fair values of $0.21 and $0.16 per option, respectively.

Note 17 - Income Taxes

Note 17 - Income Taxes	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Income Tax Disclosure [Text Block]	1 7 . Income Taxes Significant components of deferred tax assets are as follows: Years Ended December 31, 2015 2014 Loss carry forwards $ 53,693 $ 53,310 Derivative valuations (955 ) (178 ) NQSO 1,710 1,111 Tax Credits 433 433 Other 198 272 Total deferred tax asset 55,079 54,948 Valuation allowance (55,079 ) (54,948 ) Total deferred tax asset, net - - The following table accounts for the differences between the expected federal tax benefit (based on the statutory U.S. federal income tax rate of 34%) and the actual tax provision: Years Ended December 31, 2015 2014 2013 Expected federal tax benefit -34.0 % -34.0 % -34.0 % Permanent items 0.4 % 0.1 % 0.1 % Net operating loss utilized or expired 0.0 % 0.0 % 0.0 % Increase in valuation allowance and others 33.6 % 33.9 % 33.9 % Effective tax rate 0 % 0 % 0 % As of December 31, 2015, the Company had approximately $141.6 million of net operating loss (“NOL”) carryforwards for U.S. federal income tax purposes expiring in 2018 through 2035. As of December 31, 2015, the Company had approximately $95.1 million of NOL carryforwards for California income tax purposes expiring in 2016 through 2035, respectively. The Company and Liquidmetal Golf, Inc. file on a separate company basis for federal income tax purposes. Accordingly, the federal NOL carryforwards of one legal entity are not available to offset federal taxable income of the other. Liquidmetal Golf, Inc. had approximately $35.9 million in federal NOL carryforwards, expiring in 2018 through 2035. We recognize excess tax benefits associated with the exercise of stock options directly to stockholders’ equity only when realized. Accordingly, deferred tax assets are not recognized for NOL carryforwards resulting from excess tax benefits. As of December 31, 2015, deferred tax assets do not include approximately $96 of these tax effected excess tax benefits from employee stock option exercise that are a component of our NOL carryforwards. Accordingly, additional paid-in capital will increase up to an additional $96 if and when such excess tax benefits are realized. As of December 31, 2015, the Company had approximately $189 of Research & Development (“R&D”) credit carryforwards for U.S. federal income tax purposes expiring in 2021 through 2030. In addition, the Company has California R&D credit carryforwards of approximately $243, which do not expire under current California law. Section 382 of the Internal Revenue Code (“IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. As a result of the completion of the complex analysis required by the IRC to determine if an ownership change has occurred, the Company has determined that its annual NOL carryforward limitation under Section 382 of the IRC is $764 per year. The ability to realize the tax benefits associated with deferred tax assets, which includes benefits related to NOL’s, is principally dependent upon the Company’s ability to generate future taxable income from operations. The Company has provided a full valuation allowance for its net deferred tax assets due to the Company’s net operating losses. The Company adopted the provisions of FASB ASC Topic 470 – Income Taxes. At the adoption date and as of December 31, 2015, the Company had no material unrecognized tax benefits and no adjustments to liabilities or operations were required. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense which were $0 for the years ended December 31, 2015, 2014 and 2013. As of December 31, 2015, the tax years 2013 through 2014, and 2010 through 2014 are subject to examination by the federal and California taxing authorities, respectively.

Note 18 - Loss Per Common Share

Note 18 - Loss Per Common Share	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Earnings Per Share [Text Block]	1 8 . Loss Per Common Share Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings. Options to purchase 41,910,734 shares of common stock at prices ranging from $0.08 to $1.44 per share were outstanding at December 31, 2015, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 27,540,899 shares of common stock at prices ranging from $0.08 to $2.33 per share were outstanding at December 31, 2014, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Options to purchase 15,734,500 shares of common stock at prices ranging from $0.08 to $2.33 per share were outstanding at December 31, 2013, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 36,509,931 shares of common stock, with prices ranging from $0.17 to $0.19 per share, outstanding at December 31, 2015 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 66,057,792 shares of common stock, with prices ranging from $0.18 to $0.49 per share, outstanding at December 31, 2014 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 67,092,382 shares of common stock, with prices ranging from $0.18 to $0.49 per share, outstanding at December 31, 2013 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

Note 19 - Segment Information

Note 19 - Segment Information	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	19. Segment Information The primary business of the Company is to develop and manufacture products and applications from amorphous alloys. As a result, the Company’s financial results are reported in a single segment.

Note 20 - Commitments and Conti

Note 20 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	20 . Commitments and Contingencies Operating Lease Commitments The Company leases its offices and warehouse facilities under various lease agreements, certain of which are subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. As of December 31, 2015 and 2014, the Company has recorded $72 and $43, respectively, of deferred rent expenses. Future minimum lease payments under non-cancelable operating leases during subsequent years are as follows: December 31, Minimum Payments 2016 206 2017 212 2018 217 2019 242 2020 248 Thereafter 599 Total $ 1,724 Rent expense was $225, $204, and $200 for the years ended December 31, 2015, 2014, and 2013, respectively.

Note 21 - 401(k) Savings Plan

Note 21 - 401(k) Savings Plan	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	21 . 401(k) Savings Plan The Company has a tax-qualified employee savings and retirement plan, or 401(k) plan. Under the 401 (k) plan, participants may elect to reduce their current compensation, on a pre-tax basis, by up to 15% of their taxable compensation or of the statutorily prescribed annual limit, whichever is lower, and have the amount of the reduction contributed to the 401(k) plan. The 401(k) plan permits the Company, in its sole discretion, to make additional employer contributions to the 401(k) plan. However, the Company did not make employer contributions to the 401(k) plan during any of the periods presented in the accompanying consolidated financial statements.

Note 22 - Related Party Transac

Note 22 - Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	22 . Related Party Transactions The Company entered into a license agreement (the “IMG License Agreement”) with Innovative Materials Group, LLC (“IMG”), a California limited liability company which is majority owned by Mr. John Kang, a former Chief Executive Officer and former Chairman of the Company , to license certain patents and technical information for the limited purpose of manufacturing certain licensed products with the Company’s first generation die cast machines. The IMG License Agreement granted a non-exclusive license to certain product categories, as well as an exclusive license to specific types of consumer eyewear products and obligated IMG to pay the Company a running royalty based on its sales of licensed products through August 5, 2021. The Company recognized $0, $6, and $8 in royalty revenues from IMG during years ended December 31, 2015, 2014, and 2013, respectively . In February 2013, Mr. Abdi Mahamedi, the Company’s Chairman, converted his 58,600 shares of Series A-1 Preferred Stock and 260,710 shares of Series A-2 Preferred Stock into a total of 10,387,883 shares of the Company’s common stock, including dividends received in the form of common stock. Mr. Thomas Steipp, the Company’s Chief Executive Officer, sold an aggregate of 400,000 shares of the common stock of the Company on August 5, 2013 pursuant to a trading plan that Mr. Steipp previously adopted under SEC Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Mr. Steipp adopted the trading plan on March 22, 2013 for the purpose of providing him with funds to satisfy certain tax liabilities as a result of the vesting on August 3, 2013 of 1,200,000 shares of Company restricted common stock held by Mr. Steipp. The restricted shares were granted to Mr. Steipp in 2010 under a previously disclosed Restricted Stock Award Agreement, dated August 3, 2010, between Mr. Steipp and the Company. On March 27, 2014, Mr. Steipp adopted a new 10b5-1 trading plan that allowed for the sale of 500,000 shares of common stock of the Company on August 4, 2014 and August 4, 2015. In September 2013, the Company entered into Change of Control Agreements with Tony Chung, the Company’s Chief Financial Officer, and certain other executive officers who are not named executive officers of the Company for SEC reporting purposes. The Change of Control Agreements provide that if the executive officer’s employment with the Company is terminated without cause during the one-year period after a change of control of the Company, then the terminated officer will receive lump sum severance compensation in an amount equal to twelve months of his then-current base salary. Under the agreements, each of the executive officers will also be entitled to the above-described severance compensation in the event he terminates his own employment within one year after a change of control because of a salary decrease or assignment to a lower-level position. In addition, upon termination, all unvested stock options related to these officers will automatically and immediately vest and shall thereafter be exercisable in accordance with the terms and provisions of the applicable award agreements. The Company has an exclusive license agreement with LLPG, Inc. (“LLPG”), a corporation owned principally by Jack Chitayat, a former director of the Company. Under the terms of the agreement, LLPG has the right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021. There were no revenues recognized from product sales and licensing fees from LLPG during the years ended December 31, 2015, 2014, or 2013. On February 27, 2013, Mr. Chitayat converted his 28,928 shares of Series A-1 Preferred Stock and 109,528 shares of Series A-2 Preferred Stock into a total of 4,626,840 shares of the Company’s common stock, including dividends received in the form of common stock. On June 1, 2012, the Company entered into the Visser MTA relating to a strategic transaction for manufacturing services and financing. In November 2013, the Company and Visser entered into arbitration proceedings to resolve disputes associated with this agreement. As part of the May 2014 settlement of these proceedings, the Company has granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014, for all fields of use other than certain excluded fields as set forth therein. Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date of the agreement. The license to the Company’s intellectual property does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement entered into in connection with the settlement (see note 3). As of December 31, 2015, Visser is a greater-than-5% beneficial owner of the Company.

Note 23 - Subsequent Events

Note 23 - Subsequent Events	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Subsequent Events [Text Block]	23 . Subsequent Events Line of Credit Facility On March 4, 2016, the Company extended its cash collateralized line of credit facility. As part of the extension, the total available borrowings under the facility was reduced to $1,000, with an equal reduction in collateral requirements. The extended facility will mature on August 25, 2016 and contains a fixed rate of interest of 2.1%.

Note 24 - Quarterly Financial I

Note 24 - Quarterly Financial Information (Unaudited)	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Quarterly Financial Information [Text Block]	24. Quarterly Financial Information (Unaudited) (in thousands, except per share data) Quarter Ended March 31, 2015 June 30, 2015 September 30, 2015 December 31, 2015 Total Revenue $ 26 $ 39 $ 42 $ 18 $ 125 Gross profit (loss) 7 (94 ) (118 ) (19 ) $ (224 ) Operating loss (2,327 ) (2,440 ) (2,372 ) (2,142 ) $ (9,281 ) Net loss and comprehensive loss (2,480 ) (2,085 ) (1,230 ) (1,522 ) $ (7,317 ) Basic and diluted net loss per common share $ (0.01 ) $ (0.01 ) $ (0.00 ) $ (0.00 ) $ (0.02 ) Quarter Ended March 31, 2014 June 30, 2014 September 30, 2014 December 31, 2014 Total Revenue $ 160 $ 153 $ 97 $ 193 $ 603 Gross profit 20 78 12 10 $ 120 Operating loss (2,165 ) (2,335 ) (2,333 ) (2,106 ) $ (8,939 ) Net loss and comprehensive loss (3,912 ) (2,509 ) (1,018 ) 881 $ (6,558 ) Basic and diluted net loss per common share $ (0.01 ) $ (0.01 ) $ (0.00 ) $ 0.00 $ (0.01 )

Note 25 - Schedule II

Note 25 - Schedule II	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES Valuation and Qualifying Accounts (in $ thousands) Balance at Additions Charged to Balance Year ended Beginning Costs and Other at End December 31, 2015 of Period Expenses Accounts Deductions of Period Uncollectible accounts - 19 - (19 ) - Deferred tax asset valuation allowance 54,948 4,451 - (4,320 ) 55,079 Total $ 54,948 $ 4,470 $ 0 $ (4,339 ) $ 55,079 Year ended December 31, 2014 Uncollectible accounts - - - - - Deferred tax asset valuation allowance 52,374 2,582 - (8 ) 54,948 Total $ 52,374 $ 2,582 $ 0 $ (8 ) $ 54,948 Year ended December 31, 2013 Uncollectible accounts 11 - - (11 ) - Deferred tax asset valuation allowance 59,877 2,843 - (10,346 ) 52,374 $ 59,888 $ 2,843 $ 0 $ (10,357 ) $ 52,374

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation.
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	Non-Controlling Interest.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal molds and bulk alloys, licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun. License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time. Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash.
Receivables, Policy [Policy Text Block]	Trade Accounts Receivable. During 2015, there were three major customers, who together accounted for 52% of total revenue. During 2014, there were four major customers, who together accounted for 84% of total revenue. During 2013, there was one major customer, who accounted for 80% of total revenue. In the future, the Company expects that a significant portion of the revenue may continue to be concentrated in a limited number of customers, even if the bulk alloys business grows. The allowance for doubtful accounts reflects management's best estimate of probable losses inherent in the trade accounts receivable. Management primarily determines the allowance based on the aging of accounts receivable balances, historical write-off experience, customer concentrations, customer creditworthiness and current industry and economic trends. The Company's provisions for uncollectible receivables are included in selling, marketing, general and administrative expense in the consolidated statements of operations and comprehensive loss. At December 31, 2015 and 2014, the Company had not recorded an allowance for doubtful accounts.
Inventory, Policy [Policy Text Block]	Inventory.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible Assets.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-lived Assets
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements. The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, trade receivables , restricted cash, accounts payable, and short-term debt approximate their carrying value due to their short maturities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy: Level 1 — Quoted prices in active markets for identical assets or liabilities; Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has one financial instrument, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 measurement inputs. Warrants are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such warrants is estimated using the Black-Scholes option -pricing model. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815 (see note 14). As of December 31, 2015, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis: Fair Value Level 1 Level 2 Level 3 Warrant liabilities - - 59 - As of December 31, 2014, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis: Fair Value Level 1 Level 2 Level 3 Warrant liabilities - - 2,005 -
Research and Development Expense, Policy [Policy Text Block]	Research and Development Expenses.
Advertising Costs, Policy [Policy Text Block]	Advertising and Promotion Expenses.
Legal Costs, Policy [Policy Text Block]	Legal Costs.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation Share-based Payment
Income Tax, Policy [Policy Text Block]	Income Taxes. Accounting for Income Taxes Under the provisions of FASB ASC Topic 740, the Company had no material unrecognized tax positions and no adjustments to liabilities or operations were required. The Company, when applicable, will recognize interest and penalties related to uncertain tax positions in income tax expense. There was no expense related to interest and penalties for the years ended December 31, 2015, 2014 and 2013, respectively.
Earnings Per Share, Policy [Policy Text Block]	Earnings Per Share.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates.
Subsequent Events, Policy [Policy Text Block]	Subsequent Events.
Supplemental Cash Flow Information, Policy [Policy Text Block]	Supplemental Cash Flow Information.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements. Revenue from Contracts with Customers In May 2014, the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective beginning January 1, 2018 and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements. Ability to Continue as a Going Concern In August 2014, the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this pronouncement is not expected to have a material impact on the Company’s consolidated financial statements and accompanying disclosures. Inventory In July 2015, the FASB issued an accounting standards update which modifies the requirements for measuring the value of inventory on a periodic basis. The new requirement will be to measure inventory at the lower of cost or net realizable value. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements. Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 2 - Summary of Significa33

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Fair Value Level 1 Level 2 Level 3 Warrant liabilities - - 59 - Fair Value Level 1 Level 2 Level 3 Warrant liabilities - - 2,005 -

Note 5 - Trade Accounts Recei34

Note 5 - Trade Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	December 31, 2015 2014 Trade accounts receivable $ 30 $ 83 Less: Allowance for doubtful accounts - - Trade accounts receivable, net $ 30 $ 83

Note 6 - Prepaid Expenses and35

Note 6 - Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Prepaid Expenses and Other Current Assets [Table Text Block]	December 31, 2015 2014 Prepaid service invoices $ 48 $ 43 Prepaid manufacturing and mold costs 118 73 Prepaid insurance premiums 192 193 Other receivables 50 65 Total 408 374

Note 8 - Property and Equipme36

Note 8 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2015 2014 Machinery and equipment $ 2,545 $ 1,903 Computer equipment 218 218 Office equipment, furnishings, and improvements 564 531 Total 3,327 2,652 Accumulated depreciation (1,957 ) (1,534 ) Total property and equipment, net $ 1,370 $ 1,118

Note 9 - Patents and Trademar37

Note 9 - Patents and Trademarks, Net (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2015 2014 Purchased and licensed patent rights $ 566 $ 566 Internally developed patents 1,664 1,664 Trademarks 148 148 Total 2,378 2,378 Accumulated amortization $ (1,808 ) $ (1,709 ) Total intangible assets, net $ 570 $ 669
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	December 31, Aggregate Amortization Expense 2016 $ 97 2017 86 2018 84 2019 83 2020 80 Thereafter 140 $ 570
Finite-lived Intangible Assets, Accumulated Amortization [TableTextBlock]	December 31, 2015 2014 Purchased and licensed patent rights $ (517 ) $ (500 ) Internally developed patents (1,177 ) (1,103 ) Trademarks (114 ) (106 ) Total $ (1,808 ) $ (1,709 )
Finite-lived Intangible Assets, Weighted Average Amortization Periods [Table Text Block]	December 31, 2015 2014 Purchased and licensed patent rights 17 17 Internally developed patents 17 17 Trademarks 10 10

Note 14 - Warrant Liabilities (

Note 14 - Warrant Liabilities (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Visser MTA July 2, 2012 Total Beginning Balance - December 31, 2014 $ 1,053 $ 952 2,005 Change in value of warrant liability, gain $ (1,019 ) $ (927 ) (1,946 ) Ending Balance - December 31, 2015 $ 34 $ 25 $ 59
Fair Value Assumptions used for Warrants Outstanding [Table Text Block]	December 31, 2015 2014 Expected life in years 1.42 - 1.50 2.42 - 2.50 Volatility 56% - 57% 96% - 97% Risk-free interest rate 1.1% 1.1% Dividend rate 0% 0%
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number of Shares Exercise Price Expiration Date 18,937,931 $ 0.174 June 1, 2017 17,572,000 $ 0.190 July 2, 2017 36,509,931

Note 16 - Stock Compensation 39

Note 16 - Stock Compensation Plan (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	December 31, 2015 2014 2013 Expected volatility 84.19% - 168.46% 157.24% - 179.87% 128.55% - 168.09% Expected dividends - - - Expected term (in years) 0.73 - 6.32 5.50 - 7.50 6.32 - 9.61 Risk-free rate 0.39% - 1.96% 1.65% - 2.22% 1.26% - 2.49%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Options outstanding at December 31, 2013 15,734,500 0.13 Granted 15,292,914 0.29 Exercised (2,242,014 ) 0.09 Forfeited (1,219,501 ) 0.20 Expired (25,000 ) 1.43 Options outstanding at December 31, 2014 27,540,899 0.21 Granted 20,285,001 0.14 Exercised (166,666 ) 0.08 Forfeited (4,933,500 ) 0.18 Expired (815,000 ) 0.64 Options outstanding at December 31, 2015 41,910,734 $ 0.18 7.8 $ - Options exercisable at December 31, 2015 10,424,408 $ 0.18 7.3 $ - Options unvested at December 31, 2015 31,486,326 $ 0.17 7.9 $ - Options vested or expected to vest at December 31, 2015 38,032,146 $ 0.18 7.8 $ -
Schedule of Supplemental Stock Option Data [Table Text Block]	December 31, 2015 2014 2013 Weighted average grant date fair value per option granted $ 0.12 $ 0.28 $ 0.08 Fair value of options vested 1,584 385 54 Cash from participants to exercise stock options 13 205 74 Intrinsic value of options exercised 8 385 22
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Range of Exercise Prices Numbers of Options Outstanding Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Number of Options Exercisable Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price $0.00 - 0.10 10,340,820 6.99 $ 0.08 4,701,724 7.01 $ 0.08 0.11 - 1.442 31,569,914 8.01 0.21 5,722,684 7.48 0.26 Total 41,910,734 10,424,408

Note 17 - Income Taxes (Tables)

Note 17 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Years Ended December 31, 2015 2014 Loss carry forwards $ 53,693 $ 53,310 Derivative valuations (955 ) (178 ) NQSO 1,710 1,111 Tax Credits 433 433 Other 198 272 Total deferred tax asset 55,079 54,948 Valuation allowance (55,079 ) (54,948 ) Total deferred tax asset, net - -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Years Ended December 31, 2015 2014 2013 Expected federal tax benefit -34.0 % -34.0 % -34.0 % Permanent items 0.4 % 0.1 % 0.1 % Net operating loss utilized or expired 0.0 % 0.0 % 0.0 % Increase in valuation allowance and others 33.6 % 33.9 % 33.9 % Effective tax rate 0 % 0 % 0 %

Note 20 - Commitments and Con41

Note 20 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	December 31, Minimum Payments 2016 206 2017 212 2018 217 2019 242 2020 248 Thereafter 599 Total $ 1,724

Note 24 - Quarterly Financial42

Note 24 - Quarterly Financial Information (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Schedule of Quarterly Financial Information [Table Text Block]	Quarter Ended March 31, 2015 June 30, 2015 September 30, 2015 December 31, 2015 Total Revenue $ 26 $ 39 $ 42 $ 18 $ 125 Gross profit (loss) 7 (94 ) (118 ) (19 ) $ (224 ) Operating loss (2,327 ) (2,440 ) (2,372 ) (2,142 ) $ (9,281 ) Net loss and comprehensive loss (2,480 ) (2,085 ) (1,230 ) (1,522 ) $ (7,317 ) Basic and diluted net loss per common share $ (0.01 ) $ (0.01 ) $ (0.00 ) $ (0.00 ) $ (0.02 ) Quarter Ended March 31, 2014 June 30, 2014 September 30, 2014 December 31, 2014 Total Revenue $ 160 $ 153 $ 97 $ 193 $ 603 Gross profit 20 78 12 10 $ 120 Operating loss (2,165 ) (2,335 ) (2,333 ) (2,106 ) $ (8,939 ) Net loss and comprehensive loss (3,912 ) (2,509 ) (1,018 ) 881 $ (6,558 ) Basic and diluted net loss per common share $ (0.01 ) $ (0.01 ) $ (0.00 ) $ 0.00 $ (0.01 )

Note 25 - Schedule II (Tables)

Note 25 - Schedule II (Tables)	12 Months Ended
	Dec. 31, 2015
Notes Tables
Summary of Valuation and Qualifying Accounts [Table Text Block]	Balance at Additions Charged to Balance Year ended Beginning Costs and Other at End December 31, 2015 of Period Expenses Accounts Deductions of Period Uncollectible accounts - 19 - (19 ) - Deferred tax asset valuation allowance 54,948 4,451 - (4,320 ) 55,079 Total $ 54,948 $ 4,470 $ 0 $ (4,339 ) $ 55,079 Year ended December 31, 2014 Uncollectible accounts - - - - - Deferred tax asset valuation allowance 52,374 2,582 - (8 ) 54,948 Total $ 52,374 $ 2,582 $ 0 $ (8 ) $ 54,948 Year ended December 31, 2013 Uncollectible accounts 11 - - (11 ) - Deferred tax asset valuation allowance 59,877 2,843 - (10,346 ) 52,374 $ 59,888 $ 2,843 $ 0 $ (10,357 ) $ 52,374

Note 2 - Summary of Significa44

Note 2 - Summary of Significant Accounting Policies (Details Textual)	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Major Customers [Member]
Concentration Risk, Percentage	100.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Major Customers [Member]
Concentration Risk, Percentage		100.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Number of Major Customers	3	2
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | Three Major Customers [Member]
Concentration Risk, Percentage	52.00%
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | Four Major Customers [Member]
Concentration Risk, Percentage		84.00%
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | One Major Customer [Member]
Concentration Risk, Percentage			80.00%
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Number of Major Customers	3	4	1
Customer Concentration Risk [Member] | Three Major Customers [Member]
Accounts Receivable, Gross, Current	$ 30,000
Customer Concentration Risk [Member] | Two Major Customers [Member]
Accounts Receivable, Gross, Current		$ 83,000
Minimum [Member]
Property, Plant and Equipment, Useful Life	1 year
Finite-Lived Intangible Asset, Useful Life	10 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life	17 years
Cash Equivalents, at Carrying Value	$ 0	0
Impairment of Long-Lived Assets Held-for-use	0	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	0	0	$ 0
Allowance for Doubtful Accounts Receivable, Current	0	0
Accounts Receivable, Gross, Current	$ 30,000	$ 83,000
Finite-Lived Intangible Asset, Useful Life	10 years	10 years
Advertising Expense	$ 76,000	$ 252,000	78,000
Interest Paid	$ 4,000	$ 0	$ 0

Note 2 - Fair Value of Items Me

Note 2 - Fair Value of Items Measured on a Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Inputs, Level 1 [Member]
Warrant liabilities
Fair Value, Inputs, Level 2 [Member]
Warrant liabilities	$ 59	$ 2,005
Fair Value, Inputs, Level 3 [Member]
Warrant liabilities
Warrant liabilities

Note 3 - Significant Transact46

Note 3 - Significant Transactions (Details Textual) - USD ($)	Dec. 06, 2013	Nov. 08, 2013	Nov. 08, 2013	Jul. 17, 2013	Jul. 02, 2012	Jun. 02, 2012	Feb. 28, 2015	Aug. 20, 2014	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2015	Jul. 15, 2015	Sep. 09, 2014
Common Stock Purchase Agreement [Member] | Weighted Average [Member]
Share Price											$ 0.19
Common Stock Purchase Agreement [Member]
Shares Subject to a Draw Down Notice, Per Share Purchase Price, Percentage		90.00%	90.00%
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors		$ 20,000,000	$ 20,000,000					$ 30,000,000
Common Stock, Par or Stated Value Per Share		$ 0.001	$ 0.001
Common Stock Subscriptions, Term								3 years
Stock Issued During Period, Value, New Issues											$ 16,000,000
Stock Issued During Period, Shares, Other		2,666,667	2,666,667
Stock Issued During Period, Shares, New Issues											85,355,615
The 2014 Purchase Agreement [Member] | Regular Purchase Notice [Member] | Maximum [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors								$ 400,000
The 2014 Purchase Agreement [Member] | Regular Purchase Notice with Minimum Purchase Price Per Share [Member]
Common Stock, Capital Shares Reserved for Future Issuance								500,000
Share Price								$ 0.30
The 2014 Purchase Agreement [Member] | Minimum [Member]
Share Price								$ 0.10
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Weighted Average Price Per Share										$ 0.13			$ 0.13
Stock Issued During Period, Shares, New Issues										12,500,000
The 2014 Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors								$ 30,000,000
Common Stock, Par or Stated Value Per Share								$ 0.001
Common Stock Subscriptions, Term								3 years
VWAP Purchase Notice, Shares Authorized, Percentage								30.00%
VWAP Purchase Notice, Purchase Price Per Share, Percentage								95.00%
Common Stock, Shares Covered by Registration Statement															75,000,000
Proceeds from Issuance of Common Stock										$ 1,568,000			$ 1,568,000
Stock Issued During Period, Value, New Issues													$ 12,500,000,000
Stock Issued During Period, Shares, New Issues										12,500,000
Stock Purchase Agreement 2013 [Member]
Common Stock Subscriptions, Term			3 years
Private Placement [Member] | Convertible Notes Payable [Member]
Debt Instrument, Face Amount					$ 12,000,000
Debt Instrument, Convertible, Conversion Price					$ 0.352
Debt Instrument, Interest Rate, Stated Percentage					8.00%
Senior Convertible Notes Arithmetic Average Percentage					87.50%
Trading Days					20 days
Trading Day Preceding Reset Date					2 days
Private Placement [Member] | Senior Convertible Notes [Member] | Weighted Average [Member]
Debt Instrument, Convertible, Conversion Price				$ 0.0774
Private Placement [Member] | Senior Convertible Notes [Member]
Debt Conversion, Converted Instrument, Shares Issued				163,641,547
Private Placement [Member] | Additional Warrants for Anti-dilution Impact [Member] | Visser MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights										18,937,931			18,937,931
Private Placement [Member] | Visser MTA Agreement [Member]
Proceeds from Issuance of Common Stock						$ 3,000,000
Stock Issued During Period, Shares, New Issues						30,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						15,000,000				18,611,079			18,611,079
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.22
Sale of Stock, Price Per Share						$ 0.10
Class of Warrant or Right, Adjusted Exercise Price of Warrants or Rights										$ 0.17			$ 0.17
Private Placement [Member]
Senior Convertible Notes Arithmetic Average Percentage					87.50%
Trading Days					20 days
Trading Day Preceding Reset Date					2 days
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					18,750,000					17,572,000			17,572,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.384					$ 0.19	$ 0.19		$ 0.19
Engel [Member]
Exclusive License Agreement, Term	10 years
Line of Credit [Member] | Collateral Pledged [Member] | Cash [Member]
Line of Credit Facility, Remaining Borrowing Capacity							$ 1,000,000
Line of Credit [Member]
Interest Expense										$ 4,000	$ 0	$ 0
Line of Credit Facility, Maximum Borrowing Capacity							$ 2,000,000
Line of Credit Facility, Interest Rate During Period							2.10%		2.10%
Short-term Debt									$ 700,000	700,000	0		$ 700,000
Regular Purchase Notice [Member]
Common Stock, Capital Shares Reserved for Future Issuance								1,000,000
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.49
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.48
Common Stock [Member]
Stock Issued During Period, Value, New Issues										$ 13,000	$ 85,000	$ 0
Stock Issued During Period, Shares, New Issues										12,500,000	85,355,615	116,136,796
Liquidmetal Golf [Member]
Noncontrolling Interest, Ownership Percentage by Parent										79.00%			79.00%
Interest Expense										$ 4,000	$ 0	$ 245,000
Common Stock, Par or Stated Value Per Share										$ 0.001	$ 0.001		$ 0.001
Proceeds from Issuance of Common Stock										$ 1,568,000	$ 16,000,000
Stock Issued During Period, Value, New Issues										1,568,000	16,000,000	$ 12,253,000
Short-term Debt										$ 700,000	$ 0		$ 700,000
Debt Conversion, Converted Instrument, Shares Issued				18,679,584

Note 4 - Liquidity and Capita47

Note 4 - Liquidity and Capital Resources (Details Textual) - USD ($)	1 Months Ended	12 Months Ended			16 Months Ended
	Aug. 20, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2015	Nov. 08, 2013	Dec. 31, 2012
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Purchase Agreement, Closing Price Per Share		$ 0.10			$ 0.10
Stock Issued During Period, Shares, New Issues		12,500,000
Stock Issued During Period, Weighted Average Price Per Share		$ 0.13			$ 0.13
The 2014 Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors	$ 30,000,000
Common Stock Subscriptions, Term	3 years
Proceeds from Issuance of Common Stock		$ 1,568,000			$ 1,568,000
Stock Issued During Period, Shares, New Issues		12,500,000
Common Stock Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors	$ 30,000,000					$ 20,000,000
Common Stock Subscriptions, Term	3 years
Stock Issued During Period, Shares, New Issues			85,355,615
Common Stock [Member]
Stock Issued During Period, Shares, New Issues		12,500,000	85,355,615	116,136,796
Restricted Cash and Cash Equivalents, and Cash and Cash Equivalents, Carrying Value		$ 4,781,000			4,781,000
Cash and Cash Equivalents, at Carrying Value		2,773,000	$ 10,009,000	$ 2,062,000	2,773,000		$ 7,162,000
Restricted Cash and Cash Equivalents, Current		2,008,000	0		$ 2,008,000
Net Cash Provided by (Used in) Operating Activities		(6,834,000)	(7,419,000)	(4,977,000)
Net Cash Provided by (Used in) Investing Activities		(2,683,000)	(1,065,000)	(197,000)
Net Cash Provided by (Used in) Financing Activities		2,281,000	16,431,000	$ 74,000
Proceeds from Issuance of Common Stock		$ 1,568,000	$ 16,000,000

Note 5 - Trade Acounts Receivab

Note 5 - Trade Acounts Receivable Table (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Accounts Receivable, Gross, Current	$ 30,000	$ 83,000
Allowance for Doubtful Accounts Receivable, Current	0	0
Trade accounts receivable, net	$ 30,000	$ 83,000

Note 6 - Prepaid Expenses and49

Note 6 - Prepaid Expenses and Other Current Assets (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Prepaid Expense and Other Assets, Current	$ 408	$ 374

Note 6 - Prepaid Expenses and50

Note 6 - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Prepaid service invoices	$ 48	$ 43
Prepaid manufacturing and mold costs	118	73
Prepaid insurance premiums	192	193
Other receivables	50	65
Total	$ 408	$ 374

Note 7 - Inventory (Details Tex

Note 7 - Inventory (Details Textual) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Inventory, Net	$ 83,000	$ 0

Note 8 - Property and Equipme52

Note 8 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cost of Sales [Member]
Depreciation	$ 29,000	$ 0	$ 0
Selling, General and Administrative Expenses [Member]
Depreciation	394,000	197,000	96,000
Depreciation	$ 423,000	$ 197,000	$ 96,000

Note 8 - Property and Equipme53

Note 8 - Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Machinery and Equipment [Member]
Property and equipment, gross	$ 2,545	$ 1,903
Computer Equipment [Member]
Property and equipment, gross	218	218
Office Equipment, Furnishings and Improvements [Member]
Property and equipment, gross	564	531
Property and equipment, gross	3,327	2,652
Accumulated depreciation	(1,957)	(1,534)
Total property and equipment, net	$ 1,370	$ 1,118

Note 9 - Patents and Trademar54

Note 9 - Patents and Trademarks, Net (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Amortization of Intangible Assets	$ 99	$ 104	$ 118

Note 9 - Patents and Trademar55

Note 9 - Patents and Trademarks (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Purchased and Licensed Patent Rights [Member]
Intangible assets, gross	$ 566	$ 566
Accumulated amortization	(517)	(500)
Internally Developed Patents [Member]
Intangible assets, gross	1,664	1,664
Accumulated amortization	(1,177)	(1,103)
Trademarks [Member]
Intangible assets, gross	148	148
Accumulated amortization	(114)	(106)
Intangible assets, gross	2,378	2,378
Accumulated amortization	(1,808)	(1,709)
Total intangible assets, net	$ 570	$ 669

Note 9 - Estimated Future Aggre

Note 9 - Estimated Future Aggregate Amortization Expense (Details) $ in Thousands	Dec. 31, 2015USD ($)
2,016	$ 97
2,017	86
2,018	84
2,019	83
2,020	80
Thereafter	$ 140

Note 9 - Accumulated Amortizati

Note 9 - Accumulated Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Purchased and Licensed Patent Rights [Member]
Finite-lived Intangible Assets, Accumulated Amortization	$ (517)	$ (500)
Internally Developed Patents [Member]
Finite-lived Intangible Assets, Accumulated Amortization	(1,177)	(1,103)
Trademarks [Member]
Finite-lived Intangible Assets, Accumulated Amortization	(114)	(106)
Finite-lived Intangible Assets, Accumulated Amortization	$ (1,808)	$ (1,709)

Note 9 - Weighted Average Amort

Note 9 - Weighted Average Amortization Periods (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Purchased and Licensed Patent Rights [Member]
Finite-Lived Intangible Asset, Useful Life	17 years	17 years
Internally Developed Patents [Member]
Finite-Lived Intangible Asset, Useful Life	17 years	17 years
Finite-Lived Intangible Asset, Useful Life	10 years	10 years

Note 10 - Short-Term Debt (Deta

Note 10 - Short-Term Debt (Details Textual) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
	Feb. 28, 2015	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Line of Credit [Member]
Short-term Debt		$ 700,000	$ 700,000	$ 0
Line of Credit Facility, Interest Rate During Period	2.10%	2.10%
Interest Expense			4,000	0	$ 0
Short-term Debt			700,000	0
Interest Expense			$ 4,000	$ 0	$ 245,000

Note 11 - Accrued Liabilities (

Note 11 - Accrued Liabilities (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Accrued Liabilities, Current	$ 947	$ 705
Employee-related Liabilities, Current	766	567
Accrued Professional Fees, Current	109	95
Accrued Rent, Current	$ 72	$ 43

Note 12 - Other Long-term Lia61

Note 12 - Other Long-term Liabilities (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Other Liabilities, Noncurrent	$ 856	$ 856
Period for Outstanding Liability	5 years

Note 13 - Convertible Notes, 62

Note 13 - Convertible Notes, Embedded Conversion Feature Liability, and Gain on Extinguishment of Debt (Details Textual) - USD ($)	Jul. 17, 2013	Jul. 02, 2012	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jul. 15, 2015
Convertible Notes Payable [Member] | Private Placement [Member]
Debt Instrument, Face Amount		$ 12,000,000
Debt Instrument, Convertible, Conversion Price		$ 0.352
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Senior Convertible Notes [Member] | Private Placement [Member] | Weighted Average [Member]
Debt Instrument, Convertible, Conversion Price	$ 0.0774
Senior Convertible Notes [Member] | Private Placement [Member]
Debt Conversion, Converted Instrument, Shares Issued	163,641,547
Debt Instrument, Periodic Payment, Principal	$ 12,000,000
Debt Instrument, Periodic Payment, Interest	$ 680,000
Private Placement [Member]
Embedded Derivatives, Addition Original Valuation		$ 8,865,000
Warrants and Rights Outstanding		5,053,000
Embedded Conversion Feature Liability and Warrants		13,918,000
Warrants and Rights Outstanding			$ 18,179,000	$ 18,179,000		$ 18,179,000
Debt Instrument, Unamortized Discount		12,000,000
Change in Face Value of Embedded Conversion Feature Liability and Warrants		$ 1,918,000
Debt Conversion, Converted Instrument, Shares Issued	18,679,584
Gains (Losses) on Extinguishment of Debt	$ 91,000				$ 91,000

Note 14 - Warrant Liabilities63

Note 14 - Warrant Liabilities (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jul. 15, 2015	Jul. 02, 2012	Jun. 30, 2012
Private Placement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.19	$ 0.19			$ 0.384
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	17,572,000				18,750,000
Derivative Liability, Noncurrent	$ 25,000	$ 952,000			$ 5,053,000
Fair Value Assumptions, Expected Term	1 year 182 days
Fair Value Assumptions, Expected Volatility Rate	56.00%
Fair Value Assumptions, Risk Free Interest Rate	1.10%
Fair Value Assumptions, Expected Dividend Rate	0.00%
Fair Value Adjustment of Warrants	$ (927,000)	$ (1,194,000)	$ 856,000
Warrants and Rights Outstanding					$ 5,053,000
Visser MTA Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.17	$ 0.18				$ 0.22
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	18,937,931	18,706,235				15,000,000
Derivative Liability, Noncurrent	$ 34,000	$ 1,053,000				$ 4,260,000
Fair Value Assumptions, Expected Term	1 year 153 days
Fair Value Assumptions, Expected Volatility Rate	57.00%
Fair Value Assumptions, Risk Free Interest Rate	1.10%
Fair Value Assumptions, Expected Dividend Rate	0.00%
Fair Value Adjustment of Warrants	$ (1,019,000)	$ (1,506,000)	1,299,000
Warrants Valued as Liability [Member]
Class of Warrant or Right, Outstanding	36,509,931	36,278,235
Warrants and Rights Outstanding	$ 59,000	$ 2,005,000
Derivative Liability, Noncurrent	$ 59,000	$ 2,005,000
Fair Value Assumptions, Risk Free Interest Rate	1.10%	1.10%
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%
Fair Value Adjustment of Warrants	$ (1,946,000)	$ (2,700,000)	$ 2,155,000
Class of Warrant or Right, Outstanding	36,509,931	66,057,792
Warrants and Rights Outstanding	$ 18,179,000	$ 18,179,000		$ 18,179,000

Note 14 - Warrant Liability (De

Note 14 - Warrant Liability (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Visser MTA Agreement [Member]
Beginning Balance - December 31, 2014	$ 1,053,000
Fair Value Adjustment of Warrants	(1,019,000)	$ (1,506,000)	$ 1,299,000
Ending Balance - December 31, 2015	34,000	1,053,000
Private Placement [Member]
Beginning Balance - December 31, 2014	952,000
Fair Value Adjustment of Warrants	(927,000)	(1,194,000)	856,000
Ending Balance - December 31, 2015	25,000	952,000
Beginning Balance - December 31, 2014	2,005,000
Fair Value Adjustment of Warrants	(1,946,000)	(2,700,000)	$ 2,155,000
Ending Balance - December 31, 2015	$ 59,000	$ 2,005,000

Note 14 - Fair Value Assumption

Note 14 - Fair Value Assumptions Used to Determine the Value of Warrants Outstanding (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Minimum [Member]
Fair Value Assumptions, Expected Term	1 year 153 days	2 years 153 days
Fair Value Assumptions, Expected Volatility Rate	56.00%	96.00%
Fair Value Assumptions, Risk Free Interest Rate
Maximum [Member]
Fair Value Assumptions, Expected Term	1 year 182 days	2 years 182 days
Fair Value Assumptions, Expected Volatility Rate	57.00%	97.00%
Fair Value Assumptions, Risk Free Interest Rate	1.10%	1.10%
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%

Note 14 - Outstanding Warrants

Note 14 - Outstanding Warrants to Acquire Shares of the Common Stock (Details)	Dec. 31, 2015$ / sharesshares
Warrant 1 [Member]
Number of Shares (in shares)	0.174
Exercise Price (in dollars per share) | $ / shares	$ 12,017
Warrant 2 [Member]
Number of Shares (in shares)	0.19
Exercise Price (in dollars per share) | $ / shares	$ 22,017
Number of Shares (in shares)	36,509,931

Note 15 - Stockholders' Equity

Note 15 - Stockholders' Equity (Details Textual) - USD ($)	Nov. 08, 2013	Nov. 08, 2013	Jul. 17, 2013	May. 01, 2009	Jun. 30, 2012	Oct. 31, 2009	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2015	Jul. 15, 2015	Sep. 09, 2014	Aug. 20, 2014	Oct. 24, 2013	Feb. 28, 2013	Feb. 27, 2013	Jul. 02, 2012	May. 02, 2009
Private Placement [Member] | Visser MTA Agreement [Member]
Stock Issued During Period, Shares, New Issues					30,000,000
Private Placement [Member] | Senior Convertible Notes [Member] | Weighted Average [Member]
Debt Instrument, Convertible, Conversion Price			$ 0.0774
Private Placement [Member] | Senior Convertible Notes [Member]
Debt Conversion, Converted Instrument, Shares Issued			163,641,547
Debt Instrument, Periodic Payment, Principal			$ 12,000,000
Debt Instrument, Periodic Payment, Interest			$ 680,000
Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							17,572,000				17,572,000							18,750,000
Warrants and Rights Outstanding																		$ 5,053,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.19	$ 0.19			$ 0.19							$ 0.384
Common Stock Purchase Agreement [Member] | Weighted Average [Member]
Share Price								$ 0.19
Common Stock Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues								85,355,615
Stock Issued During Period, Shares, Other	2,666,667	2,666,667
Stock Issued During Period, Value, New Issues								$ 16,000,000
The 2014 Purchase Agreement [Member] | Minimum [Member]
Share Price														$ 0.10
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues							12,500,000
Stock Issued During Period, Weighted Average Price Per Share							$ 0.13				$ 0.13
The 2014 Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues							12,500,000
Stock Issued During Period, Value, New Issues											$ 12,500,000,000
Common Stock, Shares Covered by Registration Statement													75,000,000
Proceeds from Issuance of Common Stock							$ 1,568,000				$ 1,568,000
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.48
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.49
Series A Preferred Stock [Member]
Preferred Stock, Shares Outstanding										506,936
Conversion of Stock, Shares Converted									506,936	792,215
Dividends Payable										$ 222,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights												29,779,557
Convertible Series A1 Preferred Stock [Member]
Preferred Stock, Shares Outstanding										105,231
Stock Issued During Period, Shares, New Issues				500,000
Share Price				$ 5
Convertible Preferred Stock, Conversion Price							$ 0.10				$ 0.10
Convertible Series A2 Preferred Stock [Member]
Preferred Stock, Shares Outstanding										401,705
Stock Issued During Period, Shares, Other				2,625,000		180,000
Share Price																			$ 5
Convertible Preferred Stock, Conversion Price							$ 0.22				$ 0.22
Common Stock [Member]
Stock Issued During Period, Shares, New Issues							12,500,000	85,355,615	116,136,796
Conversion of Stock, Shares Issued									16,896,070
Stock Issued During Period, Value, New Issues							$ 13,000	$ 85,000	$ 0
Convertible Preferred Stock, Shares Issued upon Conversion										25,669,752
Preferred Stock, Shares Outstanding							0	0	0		0
Debt Conversion, Converted Instrument, Shares Issued			18,679,584
Common Stock, Shares Authorized							700,000,000	700,000,000			700,000,000				700,000,000	500,000,000	400,000,000
Stock Issued During Period, Value, New Issues							$ 1,568,000	$ 16,000,000	$ 12,253,000
Proceeds from Issuance of Common Stock							$ 1,568,000	$ 16,000,000
Convertible Preferred Stock, Shares Issued upon Conversion									16,896,070
Preferred Stock, Value, Issued										$ 0
Adjustments to Additional Paid in Capital, Reclassification of Accrued Preferred Stock Dividends									$ 222,000
Warrants and Rights Outstanding							$ 18,179,000	$ 18,179,000			$ 18,179,000	$ 18,179,000

Note 16 - Stock Compensation 68

Note 16 - Stock Compensation Plan (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Aug. 03, 2010	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jan. 27, 2015	Jun. 28, 2012	Apr. 04, 2002
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		822,000
Equity Incentive Plan 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						30,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		25,988,734
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		3,085,001
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					40,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		15,100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		17,200,000
Restricted Stock [Member] | Chief Executive Officer [Member]
Allocated Share-based Compensation Expense		$ 182	$ 312	$ 312
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	6,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number		41,910,734	27,540,899	15,734,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		20,285,001	15,292,914
Allocated Share-based Compensation Expense		$ 1,557	$ 1,219	$ 525
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 3,904	$ 3,090
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rates Minimum		5.34%	7.01%	28.30%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value		$ 0.16	$ 0.21

Note 16 - Assumptions Used to E

Note 16 - Assumptions Used to Estimate Fair Value (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Minimum [Member]
Expected volatility	84.19%	157.24%	128.55%
Expected term (in years)	266 days	5 years 182 days	6 years 116 days
Risk-free rate	0.39%	1.65%	1.26%
Maximum [Member]
Expected volatility	168.46%	179.87%	168.09%
Expected term (in years)	6 years 116 days	7 years 182 days	9 years 222 days
Risk-free rate	1.96%	2.22%	2.49%
Expected dividends

Note 16 - Summary of Stock Opti

Note 16 - Summary of Stock Option Transactions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Options outstanding (in shares)	27,540,899	15,734,500
Options outstanding (in dollars per share)	$ 0.21	$ 0.13
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	20,285,001	15,292,914
Granted (in dollars per share)	$ 0.14	$ 0.29
Exercised (in shares)	(166,666)	(2,242,014)
Exercised (in dollars per share)	$ 0.08	$ 0.09
Forfeited (in shares)	(4,933,500)	(1,219,501)
Forfeited (in dollars per share)	$ 0.18	$ 0.20
Expired (in shares)	(815,000)	(25,000)
Expired (in dollars per share)	$ 0.64	$ 1.43
Options outstanding (in shares)	41,910,734	27,540,899
Options outstanding (in dollars per share)	$ 0.18	$ 0.21
Options outstanding at December 31, 2015	7 years 292 days
Options exercisable at December 31, 2015 (in shares)	10,424,408
Options exercisable at December 31, 2015 (in dollars per share)	$ 0.18
Options exercisable at December 31, 2015	7 years 109 days
Options unvested at December 31, 2015 (in shares)	31,486,326
Options unvested at December 31, 2015 (in dollars per share)	$ 0.17
Options unvested at December 31, 2015	7 years 328 days
Options vested or expected to vest at December 31, 2015 (in shares)	38,032,146
Options vested or expected to vest at December 31, 2015 (in dollars per share)	$ 0.18
Options vested or expected to vest at December 31, 2015	7 years 292 days

Note 16 - Supplemental Stock Op

Note 16 - Supplemental Stock Option Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Weighted average grant date fair value per option granted (in dollars per share)	$ 0.12	$ 0.28	$ 0.08
Fair value of options vested	$ 1,584,000	$ 385,000	$ 54,000
Cash from participants to exercise stock options	13,000	205,000	74,000
Intrinsic value of options exercised	$ 8,000	$ 385,000	$ 22,000

Note 16 - Summary of Stock Op72

Note 16 - Summary of Stock Options Outstanding and Exercisable by Ranges of Option Prices (Details)	12 Months Ended
	Dec. 31, 2015$ / sharesshares
Exercise Price Range 1 [Member]
Range of Exercise Prices, Lower (in dollars per share)	$ 0
Range of Exercise Prices, Uppper (in dollars per share)	$ 0.10
Numbers of options Outstanding (in shares) | shares	10,340,820
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	6 years 361 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 0.08
Number of Options Exercisable (in shares) | shares	4,701,724
Options Exercisable, Weighted Average Remaining Contractual Life (Years)	7 years 3 days
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.08
Exercise Price Range 2 [Member]
Range of Exercise Prices, Lower (in dollars per share)	0.11
Range of Exercise Prices, Uppper (in dollars per share)	$ 1.442
Numbers of options Outstanding (in shares) | shares	31,569,914
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	8 years 3 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 0.21
Number of Options Exercisable (in shares) | shares	5,722,684
Options Exercisable, Weighted Average Remaining Contractual Life (Years)	7 years 175 days
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.26
Numbers of options Outstanding (in shares) | shares	41,910,734
Number of Options Exercisable (in shares) | shares	10,424,408

Note 17 - Income Taxes (Details

Note 17 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Domestic Tax Authority [Member] | Liquidmetal Golf, Inc [Member]
Operating Loss Carryforwards	$ 35,900,000
Domestic Tax Authority [Member] | Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	189,000
Domestic Tax Authority [Member]
Operating Loss Carryforwards	141,600,000
State and Local Jurisdiction [Member] | California Franchise Tax Board [Member]
Operating Loss Carryforwards	95,100,000
State and Local Jurisdiction [Member] | Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	243,000
Employee Stock Option [Member]
Unrecognized Tax Benefits	96,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	$ 0	$ 0	$ 0
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%	34.00%
Adjustments to Additional Paid in Capital, Share-based Compensation and Exercise of Stock Options	$ 96,000
Net Operating Loss Carryforward Limitation	$ 764,000

Note 17 - Significant Component

Note 17 - Significant Components of Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Loss carry forwards	$ 53,693	$ 53,310
Derivative valuations	955	178
NQSO	1,710	1,111
Tax Credits	433	433
Other	198	272
Total deferred tax asset	55,079	54,948
Valuation allowance	$ (55,079)	$ (54,948)
Total deferred tax asset, net

Note 17 - Differences Between t

Note 17 - Differences Between the Expected Federal Tax Benefit and Actual Tax Provision (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Expected federal tax benefit	(34.00%)	(34.00%)	(34.00%)
Permanent items	0.40%	0.10%	0.10%
Net operating loss utilized or expired	0.00%	0.00%	0.00%
Increase in valuation allowance and others	33.60%	33.90%	33.90%
Effective tax rate	0.00%	0.00%	0.00%

Note 18 - Loss Per Common Sha76

Note 18 - Loss Per Common Share (Details Textual) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jul. 15, 2015
Employee Stock Option [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.08	$ 0.08	$ 0.08
Employee Stock Option [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 1.44	$ 2.33	$ 2.33
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	41,910,734	27,540,899	15,734,500
Warrant [Member] | Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.17	$ 0.18	$ 0.18
Warrant [Member] | Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.19	$ 0.49	$ 0.49
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	36,509,931	66,057,792	67,092,382
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.48
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.49
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.18	$ 0.21	$ 0.13

Note 19 - Segment Information (

Note 19 - Segment Information (Details Textual)	12 Months Ended
	Dec. 31, 2015
Number of Reportable Segments	1

Note 20 - Commitments and Con78

Note 20 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Deferred Costs, Leasing, Net, Current	$ 72	$ 43
Operating Leases, Rent Expense, Net	$ 225	$ 204	$ 200

Note 20 - Future Minimum Lease

Note 20 - Future Minimum Lease Payments (Details) $ in Thousands	Dec. 31, 2015USD ($)
2,016	$ 206
2,017	212
2,018	217
2,019	242
2,020	248
Thereafter	599
Total	$ 1,724

Note 21 - 401(k) Savings Plan (

Note 21 - 401(k) Savings Plan (Details Textual)	12 Months Ended
	Dec. 31, 2015
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	15.00%

Note 22 - Related Party Trans81

Note 22 - Related Party Transactions (Details Textual) - USD ($)	Aug. 04, 2015	Aug. 04, 2014	Aug. 05, 2013	Aug. 03, 2013	Feb. 27, 2013	Feb. 28, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
LLPG [Member]
Revenue from Related Parties							$ 0	$ 0	$ 0
Innovative Materials Group [Member]
Royalty Revenue							$ 0	$ 6,000	$ 8,000
Board of Directors Chairman [Member] | Convertible Series A1 Preferred Stock [Member]
Conversion of Stock, Shares Converted						58,600
Board of Directors Chairman [Member] | Convertible Series A2 Preferred Stock [Member]
Conversion of Stock, Shares Converted						260,710
Board of Directors Chairman [Member] | Common Stock [Member]
Conversion of Stock, Shares Issued						10,387,883
Chief Executive Officer [Member] | Common Stock [Member]
Sale of Stock, Number of Shares Issued in Transaction			400,000
Chief Executive Officer [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				1,200,000
Chief Executive Officer [Member]
Common Stock, Shares Sold	500,000	500,000
Mr. Chitayat [Member] | Convertible Series A1 Preferred Stock [Member]
Conversion of Stock, Shares Converted					28,928
Mr. Chitayat [Member] | Convertible Series A2 Preferred Stock [Member]
Conversion of Stock, Shares Converted					109,528
Common Stock [Member]
Conversion of Stock, Shares Issued					4,626,840

Note 23 - Subsequent Events (De

Note 23 - Subsequent Events (Details Textual) - Line of Credit [Member] - USD ($)	Mar. 01, 2016	Feb. 28, 2015	Sep. 30, 2015
Subsequent Event [Member] | Collateral Pledged [Member] | Cash [Member]
Line of Credit Facility, Remaining Borrowing Capacity	$ 1,000,000
Subsequent Event [Member]
Line of Credit Facility, Interest Rate During Period	2.10%
Collateral Pledged [Member] | Cash [Member]
Line of Credit Facility, Remaining Borrowing Capacity		$ 1,000,000
Line of Credit Facility, Interest Rate During Period		2.10%	2.10%

Note 24 - Quarterly Financial83

Note 24 - Quarterly Financial Information (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Revenue	$ 18,000	$ 42,000	$ 39,000	$ 26,000	$ 193,000	$ 97,000	$ 153,000	$ 160,000	$ 125,000	$ 603,000
Gross profit (loss)	(19,000)	(118,000)	(94,000)	7,000	10,000	12,000	78,000	20,000	(224,000)	120,000
Operating loss	(2,142,000)	(2,372,000)	(2,440,000)	(2,327,000)	(2,106,000)	(2,333,000)	(2,335,000)	(2,165,000)	(9,281,000)	(8,939,000)
Net loss	$ (1,522,000)	$ (1,230,000)	$ (2,085,000)	$ (2,480,000)	$ 881,000	$ (1,018,000)	$ (2,509,000)	$ (3,912,000)	$ (7,317,000)	$ (6,558,000)
Basic and diluted net loss per common share (in dollars per share)	$ 0	$ 0	$ (0.01)	$ (0.01)	$ 0	$ 0	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.01)

Note 25 - Valuation and Qualify

Note 25 - Valuation and Qualifying Accounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Allowance for Doubtful Accounts [Member]
Balance at Beginning of Period			$ 11,000
Charged to Costs and Expenses	$ 19,000
Charged to Other Accounts
Deductions	$ (19,000)		$ (11,000)
Balance at End of Period
Valuation Allowance of Deferred Tax Assets [Member]
Balance at Beginning of Period	$ 54,948,000	$ 52,374,000	$ 59,877,000
Charged to Costs and Expenses	$ 4,451,000	$ 2,582,000	$ 2,843,000
Charged to Other Accounts
Deductions	$ (4,320,000)	$ (8,000)	$ (10,346,000)
Balance at End of Period	55,079,000	54,948,000	52,374,000
Balance at Beginning of Period	54,948,000	52,374,000	59,888,000
Charged to Costs and Expenses	4,470,000	2,582,000	2,843,000
Charged to Other Accounts	0	0	0
Deductions	(4,339,000)	(8,000)	(10,357,000)
Balance at End of Period	$ 55,079,000	$ 54,948,000	$ 52,374,000